- Home
- KTTA vs ISPC Comparison
KTTA vs ISPC Comparison
Compare KTTA & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- ISPC
- Stock Information
- Founded
- KTTA 2020
- ISPC 2009
- Country
- KTTA United States
- ISPC United States
- Employees
- KTTA N/A
- ISPC N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- KTTA Health Care
- ISPC Health Care
- Exchange
- KTTA Nasdaq
- ISPC Nasdaq
- Market Cap
- KTTA 2.8M
- ISPC 3.1M
- IPO Year
- KTTA 2021
- ISPC 2021
- Fundamental
- Price
- KTTA $0.73
- ISPC $0.94
- Analyst Decision
- KTTA
- ISPC
- Analyst Count
- KTTA 0
- ISPC 0
- Target Price
- KTTA N/A
- ISPC N/A
- AVG Volume (30 Days)
- KTTA 222.0K
- ISPC 51.4K
- Earning Date
- KTTA 08-12-2025
- ISPC 08-05-2025
- Dividend Yield
- KTTA N/A
- ISPC N/A
- EPS Growth
- KTTA N/A
- ISPC N/A
- EPS
- KTTA N/A
- ISPC N/A
- Revenue
- KTTA N/A
- ISPC $8,058,631.00
- Revenue This Year
- KTTA N/A
- ISPC $35.93
- Revenue Next Year
- KTTA N/A
- ISPC N/A
- P/E Ratio
- KTTA N/A
- ISPC N/A
- Revenue Growth
- KTTA N/A
- ISPC N/A
- 52 Week Low
- KTTA $0.71
- ISPC $0.86
- 52 Week High
- KTTA $7.50
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- KTTA 33.06
- ISPC 37.62
- Support Level
- KTTA $0.71
- ISPC $0.86
- Resistance Level
- KTTA $0.80
- ISPC $0.97
- Average True Range (ATR)
- KTTA 0.04
- ISPC 0.06
- MACD
- KTTA 0.00
- ISPC -0.02
- Stochastic Oscillator
- KTTA 12.14
- ISPC 18.79
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.